[1] Sung H, Ferlay J, Siegel R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021,71(3): 209-249. DOI:10.3322/caac.21660.
[2] Oue N, Sentani K, Sakamoto N, et al. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells[J]. Int J Clin Oncol, 2019,24(7): 771-778. DOI:10.1007/s10147-019-01443-9.
[3] Conte A, Valente V, Paladino S, et al. HIPK2 in cancer biology and therapy: recent findings and future perspectives[J]. Cell Signal, 2023,101:110491. DOI:10.1016/j.cellsig.2022.110491.
[4] Clark H, Pereira V B, Zhang Z, et al. MDR-1 function protects oocyte mitochondria against the transgenerational effects of nitrogen mustard exposure [J]. Reprod Toxicol, 2020, 98: 252-259. DOI:10.1016/j.reprotox.2020.10.010.
[5] Garufi A, D'Orazi V, Pistritto G, et al. The sweet side of HIPK2[J]. Cancers (Basel), 2023,15(10): 2678. DOI: 10.3390/cancers15102678.
[6] Zhao B, Zhang S, Chen Y, et al. Risk factors for preoperative frailty in older patients with gastric cancer: a systematic review and meta-analysis[J]. Support Care Cancer, 2024,32(7):450. DOI:10.1007/s00520-024-08654-5.
[7] Díaz P, Valenzuela VM, Bravo J, et al. Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression [J]. Front Microbiol, 2018, 9: 5. DOI: 10.3389/fmicb.2018.00005.
[8] Li X, Zheng NR, Wang LH, et al. Proteomic profiling identifies signatures associated with progression of precancerous gastric lesions and risk of early gastric cancer [J]. EBioMedicine, 2021, 74: 103714. DOI: 10.1016/j.ebiom.2021.103714.
[9] Javadekar SM, Raghavan SC. Snaps and mends: DNA breaks and chromosomal translocations[J]. FEBS J, 2015, 282(14):2627-2645. DOI:10.1111/febs.13311.
[10] Srivastava M, Raghavan SC. DNA double-strand break repair inhibitors as cancer therapeutics[J]. Chem Biol, 2015, 22(1): 17-29. DOI:10.1016/j.chembiol.2014.11.013.
[11] Choi JR, Shin KS, Choi CY, et al. PARP1 regulates the protein stability and proapoptotic function of HIPK2[J]. Cell Death Dis, 2016,7(10): e2438. DOI:10.1038/cddis.2016.345.
[12] Upadhyay M, Bhadauriya P, Ganesh S. Heat shock modulates the subcellular localization, stability, and activity of HIPK2 [J]. Biochem Biophys Res Commun, 2016, 472(4): 580-584. DOI: 10.1016/j.bbrc.2016.03.035.
[13] Glenewinkel F, Cohen MJ, King CR, et al. The adaptor protein DCAF7 mediates the interaction of the adenovirus E1A oncoprotein with the protein kinases DYRK1A and HIPK2[J]. Sci Rep, 2016, 6: 28241. DOI: 10.1038/srep28241.
[14] Verdina A, Di Segni M, Amoreo CA, et al. HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage Ⅱ colorectal cancer[J]. Oncol Rep, 2021, 45(3): 899-910. DOI:10.3892/or.2020.7912.
[15] Rodriguez-Gil A, Ritter O, Hornung J, et al. HIPK family kinases bind and regulate the function of the CCR4-NOT complex [J]. Mol Biol Cell, 2016,27(12): 1969-1980. DOI: 10.1091/mbc.E15-09-0629.
[16] Ann EJ, Kim MY, Yoon JH, et al. Tumor suppressor HIPK2 regulates malignant growth via phosphorylation of Notch1 [J]. Cancer Res, 2016, 7 6(16): 4728-4740. DOI:10.1158/0008-5472.CAN-15-3310.
[17] Feng Y, Zhou L, Sun X, et al. Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies[J]. Oncotarget, 2017, 8(12): 20452-20461. DOI: 10.18632/oncotarget.14723.
[18] Alamolhodaei NS, Tsatsakis AM, Ramezani M, et al. Resveratrol as MDR reversion molecule in breast cancer: an overview [J]. Food Chem Toxicol, 2017, 103: 223-232. DOI: 10.1016/j.fct.2017.03.024.
[19] Tsyganov MM, Freidin MB, Ibragimova MK, et al. Genetic variability in the regulation of the expression cluster of MDR genes in patients with breast cancer[J]. Cancer Chemother Pharmacol, 2017, 80(2): 251-260. DOI: 10.1007/s00280-017-3354-1.
[20] Wang NN, Zhao LJ, Wu LN, et al. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line [J]. Asian Pac J Cancer Prev, 2013, 14(9): 4983-4988. DOI: 10.7314/apjcp.2013.14.9.4983.
|